Hong Kong Media Stock News

AGTech Holdings (SEHK:8279) has just posted its H1 2026 results, reporting revenue of HK$369.4 million and a net loss of HK$14.2 million, with basic EPS at -HK$0.001214. The company has seen revenue climb in recent periods, from HK$271.4 million in H1 2025 to HK$369.4 million most recently. At the same time, net income moved from a profit of HK$2.0 million to a loss. With operating margins still under pressure, investors are watching for signals that narrowing losses could eventually...

Kwoon Chung Bus Holdings (SEHK:306) just posted its H1 2026 results, reporting revenue of $1.4 billion HKD and basic EPS of 0.25 HKD as net income reached $120.8 million HKD. Looking back, the company has seen revenue move from $1.2 billion HKD a year ago to $1.1 billion HKD in H1 2025 before rebounding this half. EPS climbed from 0.01 HKD in the same period to the current 0.25 HKD. With profit margins now sitting at a much more robust level, these headline numbers set the stage for a market...

Alibaba Health Information Technology (SEHK:241) reported H1 2026 revenue of 16.3 billion CNY and basic EPS of 0.041 CNY, with net income excluding extra items at 663 million CNY. Over recent periods, revenue moved from 14.1 billion CNY in H2 2024 to 14.3 billion CNY in H1 2025, then rose to 16.3 billion CNY in H2 2025. EPS was 0.030 CNY in H2 2024, moved to 0.048 CNY in H1 2025, and landed at 0.041 CNY in H2 2025. Margins showed solid progress through these periods, helping to set the tone...

Earlier this month, Haitian International Holdings held an internal Open House event at its new production facility in Ruma, Serbia, a site that will focus on manufacturing injection molding machines and supplying spare parts tailored to the European market. This move marks a significant step in Haitian's commitment to localized production, R&D, and customer support across Europe, with built-in capacity for further expansion as regional demand evolves. We'll explore how the localization of...

CK Hutchison Holdings (SEHK:1) is exploring the possibility of listing its health and beauty retail business, AS Watson Group, on the stock market. Early talks suggest that a Hong Kong IPO and potentially a UK listing are under consideration. See our latest analysis for CK Hutchison Holdings. After a steady run of positive news, CK Hutchison Holdings’ shares have gathered real momentum, notching a 33.7% share price return since the start of the year and an impressive 43.3% total shareholder...

Legend Holdings recently announced that CEO and executive director Mr. LI Peng has resigned from the company, with Mr. YU Hao appointed as the new chief executive officer effective November 17, 2025. This leadership transition is particularly noteworthy due to Mr. YU's extensive background in technology research and innovation, highlighted by his previous role as managing director of the company's Innovation Center. We'll look at how the appointment of a technology-focused CEO could shape...

Robosense Technology (SEHK:2498) has just released its Q3 2025 results, posting revenue of 407.1 million CNY and basic EPS of -0.22 CNY. Over the last three quarters, revenue moved from 327.8 million CNY to 455.4 million CNY before settling at 407.1 million CNY, while EPS remained consistently negative. Despite ongoing losses, investors are closely watching for signs of margin recovery amid shifting top-line trends and significant market expectations. See our full analysis for Robosense...

Laopu Gold (SEHK:6181) announced two key moves at its recent EGM. The company approved an interim dividend and amendments to its Articles of Association. Both steps signal immediate implications for current shareholders. See our latest analysis for Laopu Gold. Laopu Gold’s recent board decisions seem to have reignited interest, as reflected in its remarkable year-to-date share price return of 142.62% and a one-year total shareholder return of 225.6%. While momentum has cooled a bit in the...

Vitasoy International Holdings (SEHK:345) has just released its H1 2026 earnings, reporting revenue of $6.1 billion HKD and basic EPS of 0.22 HKD for the trailing twelve months, while net income came in at 236 million HKD. Looking back, the company has seen revenue hold steady over recent periods, with $6.3 billion HKD in H2 2025 and $6.3 billion HKD in H1 2025. EPS moved from 0.22 HKD to 0.12 HKD through these intervals. Margins have become a bigger part of the story for investors, with...

Chow Tai Fook Jewellery Group (SEHK:1929) just released its H1 2026 results, posting revenue of HK$39.0 billion and basic EPS of HK$0.26, with net income at HK$2.5 billion. Looking back, the company has seen revenue move from HK$39.4 billion in H1 2025 to HK$50.2 billion in H2 2025 before the latest tally. EPS shifted from HK$0.25 to HK$0.34 and then HK$0.26. Margins held up as investors focus on how recent profit improvements fit into the wider story. See our full analysis for Chow Tai Fook...

Hong Kong Exchanges and Clearing (SEHK:388) shares have drawn investor attention following their recent price moves. Given the platform’s central role in Asia’s financial markets, these fluctuations are often viewed in relation to broader market trends. See our latest analysis for Hong Kong Exchanges and Clearing. After a remarkable rally earlier in the year, Hong Kong Exchanges and Clearing’s share price has cooled recently, with a 4.8% decline over the past month and a slight dip in the...

Tongcheng Travel Holdings (SEHK:780) just released Q3 2025 numbers, posting revenue of ¥5.5 billion and basic EPS of ¥0.42. The company has seen revenue rise from ¥4.2 billion in Q4 2024 to ¥5.5 billion this quarter, while EPS climbed from ¥0.15 to ¥0.42 over the same period. With margins holding firm and net profitability expanding, investors have clear figures to ground the latest story around the business. See our full analysis for Tongcheng Travel Holdings. Now, we are putting those...

Ascentage Pharma Group International (SEHK:6855) garnered investor interest after publishing new data from a Phase Ib study for its drug olverembatinib in patients with SDH-deficient gastrointestinal stromal tumors. See our latest analysis for Ascentage Pharma Group International. Following the announcement of encouraging new results for olverembatinib, Ascentage Pharma Group International has continued to capture investor attention, even as its share price has pulled back 6.4% over the past...

Affluent Foundation Holdings (SEHK:1757) just released its H1 2026 results, posting total revenue of $115.3 million HKD and basic EPS of 0.000799 HKD. Looking back, the company saw revenue trend from $70.4 million HKD in H2 2024 to $125.4 million HKD in H1 2025, before landing at $115.3 million HKD in this latest update. EPS moved from 0.001429 HKD to 7.8e-05 HKD during the same periods. Margins were tight across these results, with profitability metrics flashing a caution light for investors...

OKG Technology Holdings (SEHK:1499) has just reported its H1 2026 results, with total revenue at 340.9 million HKD and a basic EPS of -0.001994 HKD. The numbers reflect a continuation of unprofitable results for the company. Revenue has grown from 195.7 million HKD in H1 2025 and 123.5 million HKD in H1 2024. Investors will be closely watching margins as profit trends remain negative. See our full analysis for OKG Technology Holdings. Next up, we’ll see how these results measure up against...

With a price-to-earnings (or "P/E") ratio of 20.2x Metallurgical Corporation of China Ltd. ( HKG:1618 ) may be sending...

InnoCare Pharma (SEHK:9969) just released its latest earnings, reporting both higher revenue and a significantly smaller net loss for the nine months through September. These results are giving investors plenty to analyze right now. See our latest analysis for InnoCare Pharma. Fresh from reporting sharply reduced net losses and steadily rising revenue, InnoCare Pharma has enjoyed some serious momentum. Its share price has soared 160.98% year-to-date, and over the past year, investors have...

Amidst global concerns about AI valuations and economic uncertainties, Asian markets have mirrored some of the cautious sentiment seen in other regions. For investors interested in exploring smaller or newer companies, penny stocks continue to present intriguing opportunities despite their somewhat dated terminology. These stocks, often representing under-the-radar growth potential at lower price points, can offer significant upside when backed by strong financial health and solid fundamentals.

Semiconductor Manufacturing International (SEHK:981) just released its latest earnings, showing increased sales and net income for the nine months ending September 30, 2025. The company also projected stable or slightly higher revenue for the upcoming quarter. See our latest analysis for Semiconductor Manufacturing International. On the heels of stronger sales and upbeat guidance, Semiconductor Manufacturing International’s 1-year total shareholder return stands out at 167.9%, showing...

Guangdong Investment (SEHK:270) revealed acceptance of a HKD 2.25 billion committed term loan facility on 19 November 2025. The loan is aimed at funding general corporate needs and refinancing existing debt, subject to specific ownership-related covenants. See our latest analysis for Guangdong Investment. The new loan announcement comes as Guangdong Investment’s share price has steadily gained traction this year, climbing 14.8% year-to-date, with the latest move up to HK$7.59. Momentum has...

When close to half the companies in Hong Kong have price-to-earnings ratios (or "P/E's") below 12x, you may consider...

There wouldn't be many who think Chongqing Iron & Steel Company Limited's ( HKG:1053 ) price-to-sales (or "P/S") ratio...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

Warren Buffett famously said, 'Volatility is far from synonymous with risk.' It's only natural to consider a company's...